Trials / Conditions / HR+/HER2-negative Breast Cancer
HR+/HER2-negative Breast Cancer
3 registered clinical trials studyying HR+/HER2-negative Breast Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select S NCT05683418 | Totus Medicines | Phase 1 |
| Recruiting | Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast NCT05455619 | SynDevRx, Inc. | Phase 1 / Phase 2 |
| Unknown | A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her NCT03560856 | Assistance Publique - Hôpitaux de Paris | Phase 2 |